Mesenchymal Stem Cells Reduce Cigarette Smoke-Induced Inflammation and Airflow Obstruction in Rats via TGF-β1 Signaling

References

• Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364:613–620.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–555.
   PubMed Web of Science ®Google Scholar
• Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 2012; 122(8):2749–2755.
   PubMed Web of Science ®Google Scholar
• Nikota JK, Stämpfli MR. Cigarette smoke-induced inflammation and respiratory host defense: Insights from animal models. Pulm Pharmacol Ther 2012; 25(4):257–262.
   PubMed Web of Science ®Google Scholar
• Abreu SC, Antunes MA, Pelosi P, Mechanisms of cellular therapy in respiratory diseases. Intensive Care Med 2011; 37(9):1421–1431.
   PubMed Web of Science ®Google Scholar
• Sinclair K, Yerkovich ST, Chambers DC. Mesenchymal stem cells and the lung. Respirology 2013; 18(3):397–411.
   PubMed Web of Science ®Google Scholar
• Aliotta JM, Passero M, Meharg J, Stem cells and pulmonary metamorphosis: New concepts in repair and regeneration. J Cell Physiol 2005; 204:725–741.
   PubMed Web of Science ®Google Scholar
• Németh K, Leelahavanichkul A, Yuen PS, Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15(1):42–49.
   PubMed Web of Science ®Google Scholar
• Gupta N, Su X, Popov B, Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007; 179:1855–1863.
   PubMed Web of Science ®Google Scholar
• D'Agostino B, Sullo N, Siniscalco D, Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin Biol Ther 2010; 10(5):681–687.
   PubMed Web of Science ®Google Scholar
• Katsha AM, Ohkouchi S, Xin H, Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 2011; 19(1):196–203.
   PubMed Web of Science ®Google Scholar
• Iyer SS, Co C, Rojas M. Mesenchymal stem cells and inflammatory lung diseases. Panminerva Med 2009; 51(1):5–16.
   PubMed Web of Science ®Google Scholar
• Lee JW, Gupta N, Serikov V, Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 2009; 9(10):1259–1270.
   PubMed Web of Science ®Google Scholar
• Kean TJ, Lin P, Caplan AI, MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int 2013; 2013:732–742.
   Web of Science ®Google Scholar
• Matthay MA, Thompson BT, Read EJ, Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 2010; 138(4):965–972.
   PubMed Web of Science ®Google Scholar
• Xu J, Woods CR, Mora AL, Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007; 293:L131–141.
   PubMed Web of Science ®Google Scholar
• Weiss DJ, Casaburi R, Flannery R, A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013; 143(6):1590–1598.
   PubMed Web of Science ®Google Scholar
• Gao J, Zhan B. The effects of Ang-1, IL-8 and TGF-β1 on the pathogenesis of COPD. Mol Med Rep 2012; 6(5):1155–1159.
   Web of Science ®Google Scholar
• Königshoff M, Kneidinger N, Eickelberg O. TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Med Wkly 2009; 139:554–563.
   PubMed Web of Science ®Google Scholar
• Morty RE, Königshoff M, Eickelberg O. Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6(7):607–613.
   PubMedGoogle Scholar
• Roberts AB. Medicine: Smoke signals for lung disease. Nature 2003; 422:130–131.
   PubMed Web of Science ®Google Scholar
• Morris DG, Huang X, Kaminski N, Loss of integrin alpha(v)beta6-mediated TGFbeta activation causes Mmp12-dependent emphysema. Nature 2003; 422:169–173.
   PubMed Web of Science ®Google Scholar
• Zhen G, Xue Z, Zhao J, Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells. Cytotherapy 2010; 12:605–614.
   PubMed Web of Science ®Google Scholar
• Katsha AM, Ohkouchi S, Xin H, Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 2011; 19:196–203.
   PubMed Web of Science ®Google Scholar
• Huh JW, Kim SY, Lee JH, Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol 2011; 301:L255–266.
   PubMed Web of Science ®Google Scholar
• Guan XJ, Song L, Han FF, Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary funtion partly via VEGF-VEGF receptors. J Cell Biochem 2013; 114(2):323–335.
   PubMed Web of Science ®Google Scholar
• Vanoirbeek JA, Rinaldi M, De Vooght V, Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. Am J Respir Cell Mol Biol 2010; 42:96–104.
   PubMed Web of Science ®Google Scholar
• Yao H, Edirisinghe I, Rajendrasozhan S, Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am J Physiol Lung Cell Mol Physiol 2008; 294:L1174–1186.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8:315–317.
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378(9795):1015–1026.
   PubMed Web of Science ®Google Scholar
• Shapiro SD. Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease. Eur Respir J 2007; 29:375–378.
   PubMed Web of Science ®Google Scholar
• Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28:585–596.
   PubMed Web of Science ®Google Scholar
• Lee JW, Gupta N, Serikov V, Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther 2009; 9(10):1259–1270.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22:672–688.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87:1047–1082.
   PubMed Web of Science ®Google Scholar
• Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; 65:930–936.
   PubMed Web of Science ®Google Scholar
• Lakhdar R, Denden S, Kassab A, Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms. Exp Lung Res 2011; 37:364–375.
   PubMed Web of Science ®Google Scholar
• Fischer BM, Pavlisko E, Voynow JA. Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis 2011; 6:413–421.
   PubMed Web of Science ®Google Scholar
• Yang YC, Zhang N, Van Crombruggen K, Transforming growth factor-beta1 in inflammatory airway disease: a key for understanding inflammation and remodeling. Allergy 2012; 67(10):1193–1202.
   PubMed Web of Science ®Google Scholar
• Budd DC, Holmes AM. Targeting TGFβ superfamily ligand accessory proteins as novel therapeutics for chronic lung disorders. Pharmacol Ther 2012; 135(3):279–291.
   PubMed Web of Science ®Google Scholar
• Zandvoort A, Postma DS, Jonker MR, Altered expression of the Smad signaling pathway: implications for COPD pathogenesis. Eur Respir J 2006; 28:533–541.
   PubMed Web of Science ®Google Scholar
• Baraldo S, Bazzan E, Turato G, Decreased expression of TGF-β type II receptor in bronchial glands of smokers with COPD. Thorax 2005; 60:998–1002.
   PubMed Web of Science ®Google Scholar
• Shull MM, Ormsby I, Kier AB, Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359:693–699.
   PubMed Web of Science ®Google Scholar
• Morris DG, Huang X, Kaminski N, Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema. Nature 2003; 422:169–173.
   PubMed Web of Science ®Google Scholar
• Lixuan Z, Jingcheng D, Wenqin Y, Jianhua H, Baojun L, Xiaotao F. Baicalin attenuates inflammation by inhibiting NK-κB activation in cigarette smoke induced inflammatory models. Pulm Pharmacol Ther 2010; 23:411–419.
   PubMed Web of Science ®Google Scholar
• Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378:1015–1026.
   PubMed Web of Science ®Google Scholar